UF researcher launches novel immunotherapy trial for pediatric cancers
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
The study seeks to address anxiety-induced delays in radiation treatment.
A clinical trial offered at UF Health provided one family something that had been in short supply as they navigated the deadliest skin cancer: hope.
Researchers at the UF Health Cancer Center are conducting innovative clinical trials that aim to improve care for patients with breast cancer.
The retreat on May 10 provided practical education on the latest advancements in clinical research, fostered networking and facilitated communication.
The scholars were selected for their commitment to increasing diversity in clinical trials.
The article was published in the Journal of Oncology Navigation & Survivorship.
In an interview with OncLive, Kate Hitchcock, M.D., Ph.D., discusses total ablative therapy in patients with limited metastatic colorectal cancer.
Thomas George, M.D., FACP, was a coauthor on the study presented at the ASCO Annual Meeting. UF Health participated in the multicenter study.
In the hunt for cancer treatments, dogs are man's best friend yet again